test

Boxer Capital Management, LLC, by Aaron I Davis, Managing Member

@Boxer Capital, Llc

Latest period2024 - Q3ReportedManaged Assets$2.038BTotal holdings68
Assets growth rate7.32%Assets growth rate (2-Q avg)0.55%Continuous growth in asset value1 quarters

Portfolio positions

This chart displays the top 10 holdings in Boxer Capital, Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 68 positions.

Assets under management

The assets under management (AUM) of Boxer Capital, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 2.038B in assets, with a quarterly growth rate of 7.32% and a 2-quarter average growth rate of 0.55%. The portfolio is managed by Boxer Capital Management, LLC, by Aaron I Davis, Managing Member, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
TILInstil Bio Inc
Recent Activity
New Position
1.18%
$23.932M
355,500 shares@ $67.32 avg price
KYMRKymera Therapeutics Inc
Recent Activity
New Position
1.05%
$21.299M
450,000 shares@ $47.33 avg price
NRIXNurix Therapeutics Inc
Recent Activity
New Position
0.63%
$12.652M
563,067 shares@ $22.47 avg price
QUREUniqure Nv
Recent Activity
New Position
0.54%
$10.969M
2.225M shares@ $4.93 avg price
APGEApogee Therapeutics Inc
Recent Activity
New Position
0.52%
$10.514M
179,000 shares@ $58.74 avg price
TERNTerns Pharmaceuticals Inc
Recent Activity
New Position
0.31%
$6.272M
752,000 shares@ $8.34 avg price
SRRKScholar Rock Holding Corp
Recent Activity
New Position
0.3%
$6.008M
750,000 shares@ $8.01 avg price
SMMTSummit Therapeutics Inc
Recent Activity
New Position
0.27%
$5.475M
250,000 shares@ $21.9 avg price
BCAXBicara Therapeutics Inc.
Recent Activity
New Position
0.17%
$3.438M
135,000 shares@ $25.47 avg price
MRSNMersana Therapeutics Inc
Recent Activity
New Position
0.17%
$3.434M
1.817M shares@ $1.89 avg price